174 related articles for article (PubMed ID: 36380187)
1. Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Xu M; Bermea KC; Ayati M; Kim HB; Yang X; Medina A; Fu Z; Heravi A; Zhang X; Na CH; Everett AD; Gabrielson K; Foster DB; Paolocci N; Murphy AM; Ramirez-Correa GA
Commun Biol; 2022 Nov; 5(1):1251. PubMed ID: 36380187
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice.
Sysa-Shah P; Xu Y; Guo X; Belmonte F; Kang B; Bedja D; Pin S; Tsuchiya N; Gabrielson K
PLoS One; 2012; 7(8):e42805. PubMed ID: 22912742
[TBL] [Abstract][Full Text] [Related]
3. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex.
Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382
[TBL] [Abstract][Full Text] [Related]
4. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
[TBL] [Abstract][Full Text] [Related]
5. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
[TBL] [Abstract][Full Text] [Related]
6. Modeling cardiomyocyte signaling and metabolism predicts genotype-to-phenotype mechanisms in hypertrophic cardiomyopathy.
Khalilimeybodi A; Saucerman JJ; Rangamani P
Comput Biol Med; 2024 Jun; 175():108499. PubMed ID: 38677172
[TBL] [Abstract][Full Text] [Related]
7. EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy.
Algül S; Schuldt M; Manders E; Jansen V; Schlossarek S; de Goeij-de Haas R; Henneman AA; Piersma SR; Jimenez CR; Michels M; Carrier L; Helmes M; van der Velden J; Kuster DWD
Circ Res; 2023 Aug; 133(5):387-399. PubMed ID: 37477020
[TBL] [Abstract][Full Text] [Related]
8. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
9. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy.
Garmany R; Bos JM; Tester DJ; Giudicessi JR; Dos Remedios CG; Dasari S; Nagaraj NK; Nair AA; Johnson KL; Ryan ZC; Maleszewski JJ; Ommen SR; Dearani JA; Ackerman MJ
Circ Genom Precis Med; 2023 Apr; 16(2):e003756. PubMed ID: 36802768
[TBL] [Abstract][Full Text] [Related]
11. Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy.
Huang Y; Lu H; Ren X; Li F; Bu W; Liu W; Dailey WP; Saeki H; Gabrielson K; Abraham R; Eckenhoff R; Gao WD
Cardiovasc Res; 2020 May; 116(6):1175-1185. PubMed ID: 31424496
[TBL] [Abstract][Full Text] [Related]
12. The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.
Schramm C; Fine DM; Edwards MA; Reeb AN; Krenz M
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H231-43. PubMed ID: 22058153
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
[TBL] [Abstract][Full Text] [Related]
14. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
[TBL] [Abstract][Full Text] [Related]
15. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
Xu Z; Mei F; Liu H; Sun C; Zheng Z
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
[TBL] [Abstract][Full Text] [Related]
16. Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy.
Vakrou S; Liu Y; Zhu L; Greenland GV; Simsek B; Hebl VB; Guan Y; Woldemichael K; Talbot CC; Aon MA; Fukunaga R; Abraham MR
Sci Rep; 2021 Jun; 11(1):13163. PubMed ID: 34162896
[TBL] [Abstract][Full Text] [Related]
17. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
[TBL] [Abstract][Full Text] [Related]
18. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
